Pond_1996_Biochem.Pharmacol_52_363

Reference

Title : Identification and isolation of two rat serum proteins with A-esterase activity toward paraoxon and chlorpyrifos-oxon - Pond_1996_Biochem.Pharmacol_52_363
Author(s) : Pond AL , Coyne CP , Chambers HW , Chambers JE
Ref : Biochemical Pharmacology , 52 :363 , 1996
Abstract :

The active metabolites (oxons) of phosphorothionate insecticides can be detoxified via A-esterase hydrolysis. Two enzymes with A-esterase activity have been isolated from rat serum. Whole serum was applied to anion exchange gel (DEAE Sepharose Fast Flow) and incubated (1 hr). Tris-HCl buffer (0.05 M; pH 7.7, at 5 degrees) containing 0.25 M NaCl was added to the slurry and incubated. The decant, containing low A-esterase activity but a high protein concentration, was discarded. Further displacement of A-esterase from DEAE gel was achieved with 1.0 M NaCl in 0.05 M Tris-HCl buffer (Ph 7.7 at 5 degrees). Following desalting and concentration, further separation was achieved by gel filtration (Sephacryl S-100 HR) and two sequential preparative scale isoelectric focusings. Final fractions contained two proteins of high molecular mass (one about 200 kDa and one between 137 and 200 kDa). The apparent range of isoelectric points for the two enzymes was 4.5 to 5.6. Following native-PAGE analysis, activity stains with beta-naphthyl acetate and Fast Garnet GBC in the presence of paraoxon (10-5 M) verified that A-esterase activity was associated with both proteins. Spectropho-tometric assay detected A-esterase activity toward paraoxon, chlorpyrifos-oxon, and phenyl acetate in the final preparation.

PubMedSearch : Pond_1996_Biochem.Pharmacol_52_363
PubMedID: 8694862

Related information

Inhibitor Chlorpyrifos-oxon    Paraoxon

Citations formats

Pond AL, Coyne CP, Chambers HW, Chambers JE (1996)
Identification and isolation of two rat serum proteins with A-esterase activity toward paraoxon and chlorpyrifos-oxon
Biochemical Pharmacology 52 :363

Pond AL, Coyne CP, Chambers HW, Chambers JE (1996)
Biochemical Pharmacology 52 :363